Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bluhm Cardiovascular Institute (BCVI) is a premier cardiovascular care and research center within the Northwestern Medicine health system, headquartered in Chicago, Illinois. Established in 2005 through a transformative gift from philanthropist Neil G. Bluhm, the institute has rapidly ascended to become one of the top-ranked heart programs in the United States. BCVI integrates advanced clinical practice with cutting-edge research conducted in collaboration with the Northwestern University Feinberg School of Medicine. The institute is organized into specialized centers of excellence focusing on heart failure, heart valve disease, coronary artery disease, and rhythm disorders. It serves as a leading site for clinical trials involving novel medical devices, such as transcatheter valves, and innovative pharmacotherapies. Through its Clinical Trials Unit, BCVI provides patients with access to emerging treatments for complex cardiovascular conditions that are not yet widely available.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bluhm Cardiovascular Institute.